They've been around since the 1950s. Certainly their patents must have expired, and there should be now generic competition, unless they're gaming the system. Well, we launched our investigation in January, and By March, 3 of the four inhaler manufacturers came to our committee, came to us and said, we are voluntarily going to lower the out of pocket cost for Americans to no more than $35 per month out of pocket. And we know because we're tracking it closely, that they're doing that. And that is, we didn't even have to pass a law. (08:38–08:55)
CLAIM
Asserts that three out of four inhaler manufacturers agreed to lower costs to $35 per month voluntarily.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
